NCT07113964 2025-08-11
QL1706 With Olaparib for Previously Treated HER2-negative Breast Cancer Patients With Homologous Recombination Deficiency (HRD)
The First Affiliated Hospital with Nanjing Medical University
Phase 2 Not yet recruiting
Clinical Trials
1 trialsPreviously Treated HER2-negative Breast Cancer Patients With Homologous Recombination Deficiency × olaparib × 1 year × Clear all